Pharmacokinetics in Early Drug Research

Anon. (1994). ECVAM News & Views. ATLA 22, 7–11.

Gobas F.A.P.C. , Lahittete J.M. , Gorofalo G. , Shiu W.Y. , and MacKay D. (1988). A novel method for measuring membrane-water partition coefficients of hydrophobic organic chemicals: comparison with 1-octanol-water partitioning. Journal of Pharmaceutical Science 77, 265–272.

Watari N. , Sugiyama Y. , Kaneniwa N. , and Hiura M. (1988). Prediction of hepatic first-pass metabolism and plasma levels following intravenous and oral administration of barbiturates in the rabbit based on quantitative structure-pharmacokinetic relationships. Journal of Pharmacokinetics and Biopharmaceutics 16, 279–301.

Blaauboer B.J. , Boobis A.R. , Castell J.V. , Coecke S. , Groothuis G.M.M. , Guillouzo A. , Hall T.J. , Hawksworth G.M. , Lorenzon G. , Miltenburger H.G. , Rogiers V. , Skett P. , Villa P. , and Wiebel F.J. (1994). The practical applicability of hepatocyte cultures in routine testing. The report and recommendations of ECVAM workshop 1. ATLA 22, 231–241.

Blaauboer B.J. , Bayliss M.K. , Castell J.V. , Evelo C.T.A. , Frazier J.M. , Groen K. , Gulden M. , Guillouzo A. , Hissink A.M. , Houston J.B. , Johanson G. , de Jongh J. , Kedderis G.L. , Reinhardt C.A. , van de Sandt J.J.M. , and Semino G. (1996). The use of biokinetics and in vitro methods in toxicological risk evaluation. The report and recommendations of ECVAM workshop 15. ATLA 24, 473–497.

Iwatsube T. , Hirota N. , Ooie T. , Suzuki H. , and Sugiyama Y. (1996). Prediction of in vivo drug disposition from in vitro data based on physiological pharmacokinetics. Biopharmaceutics and Drug Disposition 17, 273–319.

Charnick S.B. , Kawai B. , Nedelman J.R. , Lemaire M. , Niederberger W. , and Sato H. (1995). Physiologically-based pharmacokinetic modelling as a tool for drug development. Journal of Pharmacokinetics and Biopharmaceutics 23, 217–235.

Barratt M.D. , Castell J.V. , Combes R.D. , Dear-den J.C. , Fentem J.H. , Gerner I. , Giuliani A. , Gray T.J.B. , Livingstone D.J. , Provan W.M. , Rutten A.A.J.J.L. , Verhaar H.J.M. , and Zbinden P. (1995). The integrated use of alternative approaches for predicting toxic hazard. The report and recommendations of ECVAM workshop 8. ATLA 23, 410–429.

Sanderson D.M. , and Earnshaw C.G. (1991). Computer prediction of possible toxic action from chemical structure, the DEREK system. Human and Experimental Toxicology 106, 267–279.

Lewis D.F.V. (1995). Three-dimensional models of human and other mammalian microsomal P450s constructed from an alignment with P450102 (P450_bm3). Xenobiotica 25, 333–366.

Mancy A. , Broto P. , Dijols S. , Dansette P.M. , and Mansuy D. (1995). The substrate binding site of human liver cytochrome P450 2C9: an approach using designed tienilic acid derivatives and molecular modelling. Biochemistry 34, 10365–10375.

Rietjens I.M.C.M. , Soffers E.M.F. , Veeger C. , and Vervoort J. (1993). Regioselectivity of cytochrome P450 catalysed hydroxylations of fluorobenzenes predicted by calculated frontier orbital substrate characteristics. Biochemistry 32, 4801–4812.

Lewis D.F.V. (1995). COMPACT and the importance of frontier orbitals in toxicity mediated by the cytochrom P450 mono-oxygenase system. Toxicology Modelling 1, 85–97.

Dearden J.C. , Barratt M.D. , Benigni R. , Bristol D.W. , Combes R.D. , Cronin M.T.D. , Judson P.N. , Payne M.P. , Richard A.M. , Tichy M. , and Yourick J.J. The development and validation of expert systems for predicting toxicity. The report and recommendations of an ECVAM/ECB workshop. ATLA 25, in press.

Houston J.B. (1994). Utility of in vitro drug metabolic clearance data in predicting in vivo metabolic clearance. Biochemical Pharmacology 47, 1469–1479.

Bayliss M.K. , Bell J.A. , Jenner W.N. , and Wilson K. (1990). The prediction of intrinsic clearance of loxtidine from kinetic studies in rat, dog and human hepatocytes. Biochemical Society Transactions 18, 1198–1199.

Frazier J.M. (1995). Biokinetic modelling and in vitro assays. Application of in vitro systems to the prediction of in vivo biokinetics. Toxicology in Vitro 9, 527–536.

Artursson P. (1990). Epithelial transport of drugs in cell culture. A model for studying the passive diffusion of drugs over intestinal absorptive (Caco-2) cells. Journal of Pharmaceutical Science 79, 476–482.

Hidalgo I.J. , Raub T.J. , and Borchardt R.T. (1989). Characterisation of the human carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. Gastroenterology 96, 736–749.

Dehouck M.P. , Jolliet-Riant P. , Bree F. , Fruchart J.C. , Cecchelli R. , and Tillement J.P. (1992). Drug transfer across the blood-brain barrier: correlation between in vitro and in vivo models. Journal of Neurochemistry 58, 1790–1797.

Audus K.L. , and Borchardt R.T. (1986). Characterization of an in vitro blood-brain barrier model system for studying drug transport and metabolism. Pharmaceutical Research 3, 81–87.

Dehouck M.P. , Mresse S. , Delorme P. , Fruchart J.C. , and Cecchelli R. (1990). An easier, reproducible, and mass-production method to study the blood-brain barrier in vitro. Journal of Neurochemistry 54, 1798–1801.

Rubin L.L. , Hall D.E. , Parter S. , Barbu K. , Cannon C. , Horner H.C. , Janatpour M. , Liaw C.W. , Manning K. , Morales J. , Tanner L.I. , Tomaselli K.J. , & Bard F. (1991). A cell culture model of the blood-brain barrier. Journal of Cell Biology 115, 1725–1735.

Artursson P. , and Karlsson J. (1991). Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochemical and Biophysical Research Communications 175, 880–885.

Atterwill C.K. , Bruinink A. , Drejer J. , Duarte E. , McFarlane Abdulla E. , Meredith C. , Nicotera P. , Regan C. , Rodríguez-Farré E. , Simpson M.G. , Smith R. , Veronesi B. , Vijverberg H. , Walum E. , and Williams D.C. (1994). In vitro neurotoxicity testing. The report and recommendations of ECVAM workshop 3. ATLA 22, 350–362.

Hawksworth G.M. , Bach P.H. , Nagelkerke J.F. , Dekant W. , Diezi J.E. , Harpur E. , Lock E.A. , MacDonald C. , Morin J-P. , Pfaller W. , Rutten A.A.J.J.L. , Ryan M.P. , Toutain H.J. , and Trevisan A. (1995). Nephrotoxicity testing in vitro. The report and recommendations of ECVAM workshop 10. ATLA 23, 713–727.

Seibert H. , Balls M. , Fentem J.H. , Bianchi V. , Clothier R.H. , Dierickx P.J. , Ekwall B. , Garle M.J. , Gómez-Lechón M.J. , Gribaldo L. , Gulden M. , Liebsch M. , Rasmussen E. , Roguet R. , Shrivastava R. , and Walum E. (1996). Acute toxicity testing in vitro and the classification and labelling of chemicals. The report and recommendations of ECVAM workshop 16. ATLA 24, 499–510.

Garle M.J. , and Fry J.R. (1989). Detection of reactive metabolites in vitro. Toxicology 54, 101–110.

Mulder G.J. , and Le C.T. (1988). A rapid, simple in vitro screening test, using [³H]-glutathione and L-[³⁵S]-cysteine as trapping agents, to detect reactive intermediates of xenobiotics. Toxicology in Vitro 2, 225–230.

Knobeloch L.M. , Blondin G.A. , Lyford S.B. , and Harkin J.M. (1990). A rapid bioassay for chemicals that induce pro-oxidant states. Journal of Applied Toxicology 10, 1–5.

Gonzalez F.J. , and Korezekwa K.R. (1995). Cytochrome P450 expression systems. Annual Reviews of Pharmacology and Toxicology 35, 369–390.

Duncan R. (1992). Drug-polymer conjugates: potential for improved chemotherapy. Anti-Cancer Drugs 3, 175–210.

Duncan R. , and Spreafico F. (1994). Polymer conjugates: pharmacokinetic considerations for design and development. Clinical Pharmacokinetics 27, 290–306.

Vasey P.A. , Duncan R. , Kaye S.B. , and Cassidy J. (1995). Clinical Phase I trial (HPMA copolymer doxorubicin). European Journal of Cancer 31A, S193.

Artursson P. (1991). Cell cultures as models for drug absorption across the intestinal mucosa. Critical Reviews of Therapeutic Drug Carrier Systems 8, 305–330.

Hillgren K.M. , Kato A. , and Borchardt R.T. (1995). In vitro systems for studying intestinal drug absorption. Medical Research Reviews 15, 83–109.

Cogburn J.N. , Donovan M.G. , and Schasten C.S. (1991). A model of human small intestinal absorptive cells. I. Transport barrier. Pharmaceutical Research 8, 210–216.

Rubas W. , Jezyk N. , and Grass G.M. (1993). Comparison of the permeability characteristics of a human colonic epithelial (Caco-2) cell line to colon of rabbit, monkey, and dog intestine and human drug absorption. Pharmaceutical Research 10, 113–118.

Wils A. , Warney A. , Phung-Ba V. , and Scherman D. (1994). Differentiated intestinal epithelial cell lines as in vitro models for predicting the intestinal absorption of drugs. Cell Biology and Toxicology 10, 393–397.

Rubas W. , Villagran J. , Cromwell M. , McLeod A. , Wassenberg J. , and Mesny R. (1995). Correlation of solute flux across Caco-2 monolayers and colonic tissue in vitro. S.T.P. Pharmaceutical Sciences 1, 93–97.

Stewart B.H. , Chan H. , Lu R.H. , Reyner E.L. , Schmid H.L. , Hamilton H.W. , Steinerg B.A. , and Taylor M.D. (1995). Comparison of intestinal permeabilities determined in multiple in vitro and in situ models: relationship to absorption in humans. Pharmaceutical Research 12, 693–699.

Lennernas H. , Palm K. , Fagerholm V. , and Artursson P. (1996). Correlation between paracellular and transcellular drug permeability in the human jejunum and Caco-2 monolayers. International Journal of Pharmaceutics 127, 103–107.

Artursson P. , Ungell A.L. , and Lofroth J.E. (1993). Selective paracellular permeability in two models of intestinal absorption: cultured monolayers of human intestinal epithelial cells and rat intestinal segments. Pharmaceutical Research 10, 1123–1129.

Artursson P. , Karlsson J. , Ocklind G. , and Schipper N. (1996). Studying transport processes in absorptive epithelia. In Cell Culture Models of Epithelial Tissues — A Practical Approach (ed. Shaw A. ), pp. 111–133. New York: Oxford University Press.

Walter E. , and Kissel T. (1994). Heterogeneity in the human intestinal cell line Caco-2 leads to differences in transepithelial transport. European Journal of Pharmaceutical Science 3, 656–671.

Martin Y.C. (1981). A practitioner's perspective of the role of quantitative structure-activity analysis in medicinal chemistry. Journal of Medicinal Chemistry 24, 229–237.

Young R.C. , Mitchell R.C. , Brown T.H. , Ganellin R.C. , Griffiths R. , Jones M. , Rana K.K. , Saunders D. , Smith I.R. , Sore N.E. , and Wilks T.J. (1988). Development of a new physico-chemical model for brain penetration and its application to the design of centrally acting H₂ receptor histamine antagonists. Journal of Medicinal Chemistry 31, 656–671.

Wright L.L. , and Painter G.R. (1992). Role of desolvation energy in the non-facilitated membrane permeability of dideoxyribose analogs of thymidine. Molecular Pharmacology 41, 957–962.

Palm K. , Luthman K. , Ungell A.L. , Strandlund G. , and Artursson P. (1996). Correlation of drug absorption with molecular surface properties. Journal of Pharmaceutical Science 85, 32–39.

Stevenson C.L. , Augustijns P.F. , and Hendren R.W. (1995). Permeability screen for synthetic peptide combinatorial libraries using Caco-2 cell monolayers and LC/MS/MS. Pharmaceutical Research 12, S94.

van Bree J.B.M.M. , de Boer A.G. , Danhof M. , Ginsel L.A. , and Breimer D.D. (1988). Characterization of in vitro blood-brain barrier: effects of molecular size and lipophilicity on cerebrovascular endothelial transport rates of drugs. Journal of Pharmacology and Experimental Therapeutics 247, 1233–1239.

van Bree J.B.M.M. , de Boer A.G. , Danhof M. , and Breimer D.D. (1992). Drug transport across the blood-brain barrier. II. Experimental techniques to study drug transport. Pharmaceutica Weekblad (Sci) 14, 338–348.

Joo F. (1993). The blood-brain barrier in vitro: the second decade. Neurochemistry International 23, 499–521.

Meyer J. , Rauh J. , & Galla H-J. (1991). The susceptibility of cerebral endothelial cells to astroglial induction of blood-brain barrier enzymes depends on their proliferative state. Journal of Neurochemistry 57, 1971–1977.

Mresse S. , Dehouck M-P. , Delorme P. , Bensad M. , Tauber J.P. , Delbart D. , Fruchart J-C. , & Cecchelli R. (1989). Bovine brain endothelial cells express tight junctions and monoamine oxidase activity in long-term culture. Journal of Neurochemistry 53, 1363–1371.

de Vries H.E. , Blom-Roosemalen M.C.M. , de Boer A.G. , van Berkel T.J.C. , Breimer D.D. , and Kuiper J. (1996). Effect of endotoxin on the permeability of bovine cerebral endothelial cell layers in vitro. Journal of Pharmacology and Experimental Therapeutics 277, 1418–1423.

de Vries H.E. , Blom-Roosemalen M.C.M. , de Boer A.G. , van Berkel T.J.C. , Breimer D.D. , and Kuiper J. (1996). The influence of cytokines on the integrity of the blood-brain barrier in vitro. Journal of Neuroimmunology 64, 37–43.